Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DT.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DT.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.77 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.77 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.77 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.10.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.10.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.10.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EF.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used